Edgewise Therapeutics

Edgewise Therapeutics is a biotechnology company focused on developing novel therapies for serious muscle diseases. They are driven by a commitment to patients and their families, aiming to improve the lives of those affected by debilitating skeletal and cardiac muscle disorders. Edgewise’s research is based on a deep understanding of muscle biology and their proprietary muscle-focused platform, which informs their therapeutic development across various serious diseases. Their lead compounds, Sevasemten and EDG-7500, are currently in clinical trials and show promising potential to address the unmet needs of patients suffering from Becker and Duchenne muscular dystrophy, and hypertrophic cardiomyopathy.

Edgewise prioritizes a patient-centric approach, working to understand the challenges faced by individuals living with these conditions. Their culture is inspiring, pioneering, and science-forward, dedicated to developing innovative treatments that truly make a difference. They have established a strong presence in the scientific community, engaging with patients, families, researchers, and clinicians to foster collaboration and accelerate the development of new therapies. Their commitment to excellence, courage, and connection drives their mission to build the world's leading muscle-focused company and ultimately, improve the lives of those living with serious muscle diseases.

Edgewise Therapeutics offers a flexible work environment that allows employees to work globally or at their headquarters. While the job posting doesn't specifically mention remote work, it highlights the company's commitment to a work culture that allows employees to achieve their full potential, suggesting flexibility in how and where they work.

Edgewise Therapeutics is a biotechnology company dedicated to developing novel therapies for serious skeletal and cardiac muscle diseases. With a singular focus on muscle science, they aim to address the root causes of muscle breakdown and dysfunction, ultimately improving the lives of patients and families affected by these debilitating conditions. They are driven by a patient-centered approach, prioritizing the needs of those living with muscle disease and working tirelessly to bring life-changing medicines to market.

Edgewise Therapeutics promotes a culture that is both science-forward and patient-centric, emphasizing collaboration, innovation, and a commitment to developing life-changing medicines. The company values connection, excellence, and courage, fostering a supportive and inclusive environment where employees are encouraged to think creatively, embrace challenges, and celebrate successes. This culture is driven by a deep appreciation for the needs of patients and families suffering from serious muscle diseases, creating a sense of purpose and motivation among employees.

Edgewise Therapeutics prioritizes building a diverse, equitable, and inclusive workplace that values different perspectives and experiences. They believe that a diverse workforce strengthens their scientific endeavors and their commitment to developing life-changing medicines for patients with serious muscle diseases. Their approach emphasizes connection, excellence, and courage, creating an environment that fosters respect, celebrates success, and embraces learning from both triumphs and setbacks.